Intensive blood pressure therapy is associated with a significantly lower risk for serious cardiovascular events in the adults with diabetes.
The sBLA includes results from the Phase 3 PANORAMA trial, which enrolled 402 patients with NPDR.
Investigators examined whether the use of glucagon-like peptide-1 receptor agonists is associated with an increased risk for incident diabetic retinopathy.
Investigators assessed the effect of complication burden and concurrent risk factors level on the risk of developing further microvascular complication.
Investigators examined the effect of bariatric surgery and the incidence of microvascular complications in type 2 diabetes.
Investigators sought to determine the safety and efficacy of electroacupuncture for painful diabetic peripheral neuropathy.
Investigators examined cardiometabolic risk factor trajectories in patients diagnosed with type 2 diabetes over the course of 13 years preceding diabetic polyneuropathy.
A clinical trial assessing canagliflozin (Invokana; Janssen) as an addition to standard-of-care in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) has been stopped early after meeting its pre-specified efficacy criteria.
Popliteal Sciatic Nerve Block May Increase Time to First Opioid Request in Diabetic Peripheral NeuropathyJuly 16, 2018
Patients with type 2 diabetes and diabetic peripheral neuropathy may have an increased time to first opioid request and reduced time to onset of sensory blockade after an ultrasound-guided popliteal sciatic nerve block compared with patients without neuropathy.
ISPAD recommends adjustments for fluid management regarding rehydration rates in children and adolescents with diabetes ketoacidosis.
A sustained-release formulation of sodium nitrite may not be associated with headaches and dizziness reported by patients treated with the immediate-release formulation of sodium nitrite for diabetic peripheral neuropathy.
The paradoxical finding of accelerated wound healing and increase in HbA1c in participants with better baseline glycemic control requires confirmation in further studies.
There is a high risk of postoperative mortality among patients undergoing lower-limb amputation.
This is the first device authorized for marketing that provides a screening decision without the need for clinician interpretation.
Study provides stronger epidemiological evidence for obesity as a risk factor for diabetic polyneuropathy.
For patients with diabetic macular edema, repeated ranibizumab treatment does not appear to be associated with impaired macular perfusion.
Growth hormone-releasing hormone (GHRH) agonists protect against diabetic retinopathy in animal modelJanuary 19, 2018
GHRH and GHRH receptor levels are decreased in diabetic rats and humans. Administration of GHRH agonists to diabetic rats reversed signs of diabetic retinopathy.
The FDA has granted marketing clearance of the first shock wave device intended for use in the treatment of chronic, full-thickness diabetic foot ulcers.
As many as one-quarter of individuals with diabetes will experience painful neuropathic symptoms for which treatment is limited.
Among Asians, individuals with mild and moderate diabetic retinopathy are more likely to have fallen, and greater perceived barriers to diabetes self-management are associated with the severity of DR in an Asian population.
Twenty-five percent of people with type 2 diabetes and 12% of people with type 1 diabetes had depression.
Although the incidence of severe hypoglycemia has decreased while insulin pump use has increased, a causal relationship has not been established between insulin administration methods and risk of complications from diabetes.
Painful diabetic neuropathy affects approximately one-quarter of people with diabetes.
The efficacy and safety profile of hyperbaric oxygen therapy remains controversial because of conflicting data and small sample sizes in clinical trials.
A phase 2 clinical trial examined the efficacy of treating painful diabetic neuropathy (PDN) with filorexant, an orexin receptor antagonist.
Obstructive sleep apnea is associated with sight-threatening diabetic retinopathy in patients with type 2 diabetes.
Researchers examined 22 randomized controlled trials to evaluate effects of various treatments on diabetic foot ulcers.
New recommendations suggest that frequency of diabetic retinopathy screening should be guided by patients' HbA1c levels.
Diabetic ketoacidosis led to fatal demise, preterm birth, and neonatal intensive care unit admissions.
A pooled analysis examined the rates of amputation and fracture in patients with type 2 diabetes prescribed empagliflozin.
Endocrinology Advisor Articles
- Trends in Cardiovascular Deaths for US Adults With and Without Diabetes
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Comparing Efficacies of Second-Line Treatments in Type 2 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Behavioral Weight Loss Interventions May Prevent Obesity
- Disaster Preparedness 101: Physician Resources for Patients
- Assessing the Environmental Impact of the Healthcare Industry
- Medical Schools Phase Out Lectures as Education Shifts Outside the Classroom
- Clonidine Testing Is Safe and Reliable for Diagnosing Growth Hormone Deficiency